Empfehlung
7,6
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Stammdaten
Unternehmen
| Name | COLLEGIUM PHARMACEUTICAL, INC |
|---|---|
| Ticker | COLL |
| CIK | 0001267565 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | COLLEGIUM PHARMACEUTICAL, INC |
Status
| Zuletzt geprüft | 2026-03-20 22:36:18.473607 |
|---|
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 780,567,000 | 62,870,000 | 1.73 | 1,656,834,000 | 301,675,000 |
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-18 | Dieter David | Officer, EVP & General Counsel | Open Market Sale | -13,976 | 34.92 | -488,099.22 | -91,9% | |
| 2026-03-18 | Dieter David | Officer, EVP & General Counsel | Open Market Sale | -13,976 | 34.92 | -488,099.22 | -91,9% | |
| 2026-03-09 | Dieter David | Officer, EVP & General Counsel | Open Market Sale | -6,224 | 36.65 | -228,109.60 | -43,0% | |
| 2026-03-09 | Dieter David | Officer, EVP & General Counsel | Open Market Sale | -6,224 | 36.65 | -228,109.60 | -43,0% | |
| 2026-03-09 | Dieter David | Officer, EVP & General Counsel | Open Market Sale | -6,224 | 36.65 | -228,109.60 | -43,0% | |
| 2026-03-03 | Dreyer Scott | Officer, EVP & Chief Commercial Officer | Open Market Sale | -46,417 | 40.36 | -1,873,557.22 | -352,9% | |
| 2026-03-03 | Dreyer Scott | Officer, EVP & Chief Commercial Officer | Open Market Sale | -3,559 | 40.99 | -145,879.50 | -27,5% | |
| 2025-12-08 | Dreyer Scott | Officer, EVP & Chief Commercial Officer | Open Market Sale | -6,475 | 48.66 | -315,084.51 | -59,4% | |
| 2025-12-08 | Dreyer Scott | Officer, EVP & Chief Commercial Officer | Open Market Sale | -11,125 | 47.89 | -532,770.69 | -100,4% | |
| 2025-12-05 | Balice-Gordon Rita J. | Director | Open Market Sale | -3,650 | 47.03 | -171,673.37 | -32,3% | |
| 2025-11-12 | Fallon John A. | Director | Open Market Sale | -34,853 | 47.21 | -1,645,535.60 | -310,0% | |
| 2025-11-06 | Tupper Colleen | Officer, EVP & Chief Financial Officer | Open Market Sale | -4,858 | 41.28 | -200,516.86 | -37,8% | |
| 2025-11-06 | Tupper Colleen | Officer, EVP & Chief Financial Officer | Open Market Sale | -25,142 | 40.38 | -1,015,236.47 | -191,2% | |
| 2025-08-15 | SANTINI GINO | Director | Open Market Sale | -5,405 | 37.19 | -201,018.44 | -37,9% | |
| 2025-08-15 | SANTINI GINO | Director | Open Market Sale | -5,405 | 37.19 | -201,018.44 | -37,9% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.